BIOCARESD Trademark

Trademark Overview


On Wednesday, October 24, 2018, a trademark application was filed for BIOCARESD with the United States Patent and Trademark Office. The USPTO has given the BIOCARESD trademark a serial number of 88168019. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Saturday, May 3, 2025. This trademark is owned by BioCare, Inc.. The BIOCARESD trademark is filed in the Advertising, Business and Retail Services and Transportation & Storage Services categories with the following description:

Distribution services, namely, delivery of therapeutic plasma-derivatives and recombinant coagulation products used for hemophilia and thrombophilia treatment, immunology, wound management, and critical care; biopharmaceutical and specialty pharmaceutical distribution services, namely, transport, delivery, packaging and storage of therapeutic plasma-derivatives and recombinant coagulation products for hospitals, clinics, home care companies, hemophilia and thrombosis centers, and physician offices

Consignment inventory services, namely, inventory management in the field of biologic and specialty pharmaceutical products in the nature of therapeutic plasma-derivatives and recombinant coagulation products provided to hospitals, clinics, home care companies, hemophilia and thrombosis centers, and physician offices
biocaresd

General Information


Serial Number88168019
Word MarkBIOCARESD
Filing DateWednesday, October 24, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSaturday, May 3, 2025
Registration Number5853299
Registration DateTuesday, September 3, 2019
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 19, 2019

Trademark Statements


Description of MarkThe mark consists of the letters "BioCareSD" where the letter "a" is the design of a stylized heart.
Goods and ServicesDistribution services, namely, delivery of therapeutic plasma-derivatives and recombinant coagulation products used for hemophilia and thrombophilia treatment, immunology, wound management, and critical care; biopharmaceutical and specialty pharmaceutical distribution services, namely, transport, delivery, packaging and storage of therapeutic plasma-derivatives and recombinant coagulation products for hospitals, clinics, home care companies, hemophilia and thrombosis centers, and physician offices
Pseudo MarkBIO CARE SD
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesConsignment inventory services, namely, inventory management in the field of biologic and specialty pharmaceutical products in the nature of therapeutic plasma-derivatives and recombinant coagulation products provided to hospitals, clinics, home care companies, hemophilia and thrombosis centers, and physician offices

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, November 7, 2018
Primary Code035
First Use Anywhere DateMonday, April 22, 2019
First Use In Commerce DateMonday, April 29, 2019

International Class039 - Transport; packaging and storage of goods; travel arrangement.
US Class Codes100, 105
Class Status Code6 - Active
Class Status DateWednesday, November 7, 2018
Primary Code039
First Use Anywhere DateMonday, April 22, 2019
First Use In Commerce DateMonday, April 29, 2019

Trademark Owner History


Party NameBioCare, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTempe, AZ 85282

Party NameBioCare, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTempe, AZ 85282

Party NameBioCare, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTempe, AZ 85282

Trademark Events


Event DateEvent Description
Wednesday, February 6, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, October 27, 2018NEW APPLICATION ENTERED
Wednesday, November 7, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 31, 2019ASSIGNED TO EXAMINER
Wednesday, February 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 19, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 19, 2019PUBLISHED FOR OPPOSITION
Tuesday, May 14, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 11, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 11, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 1, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 25, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, June 25, 2019USE AMENDMENT FILED
Wednesday, July 17, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 17, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 2, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 3, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 3, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, January 15, 2025TEAS SECTION 8 & 15 RECEIVED
Saturday, May 3, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, May 3, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, May 3, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED